HSP47 in lung fibroblasts is a predictor of survival in fibrotic nonspecific interstitial pneumonia

Respiratory Medicine

Volumn 104, Issue 6, 2010, Pages 895-901

  Amenomori, Misato ^a   Mukae, Hiroshi ^a,d   Sakamoto, Noriho ^a   Kakugawa, Tomoyuki ^a   Hayashi, Tomayoshi ^b   Hara, Atsuko ^a   Hara, Shintaro ^a   Fujita, Hanako ^a   Ishimoto, Hiroshi ^a   Ishimatsu, Yuji ^a   Nagayasu, Takeshi ^c   Kohno, Shigeru ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NAGASAKI UNIVERSITY HOSPITAL   (Japan)

^c NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

^d UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

Collagen vascular disease; Fibrotic interstitial pneumonia; Fibrotic nonspecific interstitial pneumonia; Heat shock protein 47; Usual interstitial pneumonia

Indexed keywords

HEAT SHOCK PROTEIN 47;

ADULT; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IDIOPATHIC DISEASE; INTERSTITIAL PNEUMONIA; LUNG BIOPSY; LUNG FIBROBLAST; LUNG FIBROSIS; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; VASCULAR DISEASE; AGED; FIBROBLAST; GENETICS; IMMUNOHISTOCHEMISTRY; INTERSTITIAL LUNG DISEASE; LUNG; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; SURVIVAL RATE;

AGED; FEMALE; FIBROBLASTS; HSP47 HEAT-SHOCK PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; PROGNOSIS; PULMONARY FIBROSIS; SURVIVAL RATE;

EID: 77952320851     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2010.01.011     Document Type: Article

References (31)

1. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med 165 (2002) 277-304
2. Latsi P.I., du Bois R.M., Nicholson A.G., et al. Fibrotic idiopathic interstitial pneumonia: the prognostic value of longitudinal functional trends. Am J Respir Crit Care Med 168 (2003) 531-537
3. Jegal Y., Kim D.S., Shim T.S., et al. Physiology is a stronger predictor of survival than pathology in fibrotic interstitial pneumonia. Am J Respir Crit Care Med 171 (2005) 639-644
4. Park J.H., Kim D.S., Park I.N., et al. Prognosis of fibrotic interstitial pneumonia: idiopathic versus collagen vascular disease-related subtypes. Am J Respir Crit Care Med 175 (2007) 705-711
5. Travis W.D., Hunninghake G., King Jr. T.E., et al. Idiopathic nonspecific interstitial pneumonia: report of an American Thoracic Society project. Am J Respir Crit Care Med 177 (2008) 1338-1347
6. Nagai S., Handa T., Tabuena R., Kitaichi M., and Izumi T. Nonspecific interstitial pneumonia: a real clinical entity?. Clin Chest Med 25 (2004) 705-715
7. Kinder B.W., Collard H.R., Koth L., et al. Idiopathic nonspecific interstitial pneumonia: lung manifestation of undifferentiated connective tissue disease?. Am J Respir Crit Care Med 176 (2007) 691-697
8. Nicholson A.G., Colby T.V., du Bois R.M., Hansell D.M., and Wells A.U. The prognostic significance of the histologic pattern of interstitial pneumonia in patients presenting with the clinical entity of cryptogenic fibrosing alveolitis. Am J Respir Crit Care Med 162 (2000) 2213-2217
9. Sato T., Fujita J., Yamadori I., et al. Non-specific interstitial pneumonia as the first clinical presentation of various collagen vascular disorders. Rheumatol Int 26 (2006) 551-555
10. Flaherty K.R., Colby T.V., Travis W.D., et al. Fibroblastic foci in usual interstitial pneumonia: idiopathic versus collagen vascular disease. Am J Respir Crit Care Med 167 (2003) 1410-1415
11. Shioshita K., Miyazaki M., Ozono Y., et al. Expression of heat shock proteins 47 and 70 in the peritoneum of patients on continuous ambulatory peritoneal dialysis. Kidney Int 57 (2000) 619-631
12. Nagata K. Therapeutic strategy for fibrotic diseases by regulating the expression of collagen-specific molecular chaperone HSP47. Nippon Yakurigaku Zasshi 121 (2003) 4-14
13. Kakugawa T., Mukae H., Hayashi T., et al. Expression of HSP47 in usual interstitial pneumonia and nonspecific interstitial pneumonia. Respir Res 6 (2005) 57
14. Iwashita T., Kadota J., Naito S., et al. Involvement of collagen-binding heat shock protein 47 and procollagen type I synthesis in idiopathic pulmonary fibrosis: contribution of type II pneumocytes to fibrosis. Hum Pathol 31 (2000) 1498-1505
15. Kuhn C., and McDonald J.A. The roles of the myofibroblast in idiopathic pulmonary fibrosis. Ultrastructural and immunohistochemical features of sites of active extracellular matrix synthesis. Am J Pathol 138 (1991) 1257-1265
16. Selman M., King T.E., and Pardo A. Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med 134 (2001) 136-151
17. Katzenstein A.L., and Myers J.L. Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification. Am J Respir Crit Care Med 157 (1998) 1301-1315
18. Cooper Jr. J.A. Pulmonary fibrosis: pathways are slowly coming into light. Am J Respir Cell Mol Biol 22 (2000) 520-523
19. King Jr. T.E., Schwarz M.I., Brown K., et al. Idiopathic pulmonary fibrosis: relationship between histopathologic features and mortality. Am J Respir Crit Care Med 164 (2001) 1025-1032
20. Nicholson A.G., Fulford L.G., Colby T.V., et al. The relationship between individual histologic features and disease progression in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 166 (2002) 173-177
21. Bjoraker J.A., Ryu J.H., Edwin M.K., et al. Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 157 (1998) 199-203
22. Travis W.D., Matsui K., Moss J., and Ferrans V.J. Idiopathic nonspecific interstitial pneumonia: prognostic significance of cellular and fibrosing patterns: survival comparison with usual interstitial pneumonia and desquamative interstitial pneumonia. Am J Surg Pathol 24 (2000) 19-33
23. Daniil Z.D., Gilchrist F.C., Nicholson A.G., et al. A histologic pattern of nonspecific interstitial pneumonia is associated with a better prognosis than usual interstitial pneumonia in patients with cryptogenic fibrosing alveolitis. Am J Respir Crit Care Med 160 (1999) 899-905
24. Flaherty K.R., Toews G.B., Travis W.D., et al. Clinical significance of histological classification of idiopathic interstitial pneumonia. Eur Respir J 19 (2002) 275-283
25. Nakamura Y., Chida K., Suda T., et al. Nonspecific interstitial pneumonia in collagen vascular diseases: comparison of the clinical characteristics and prognostic significance with usual interstitial pneumonia. Sarcoidosis Vasc Diffuse Lung Dis 20 (2003) 235-241
26. Fujita J., Ohtsuki Y., Yoshinouchi T., et al. Idiopathic non-specific interstitial pneumonia: as an autoimmune interstitial pneumonia. Respir Med 99 (2005) 234-240
27. Mosca M., Tani C., Neri C., Baldini C., and Bombardieri S. Undifferentiated connective tissue diseases (UCTD). Autoimmun Rev 6 (2006) 1-4
28. Masuda H., Fukumoto M., Hirayoshi K., and Nagata K. Coexpression of the collagen-binding stress protein HSP47 gene and the alpha 1(I) and alpha 1(III) collagen genes in carbon tetrachloride-induced rat liver fibrosis. J Clin Invest 94 (1994) 2481-2488
29. Pan H., and Halper J. Regulation of heat shock protein 47 and type I procollagen expression in avian tendon cells. Cell Tissue Res 311 (2003) 373-382
30. Yoshioka S., Mukae H., Ishii H., et al. Alpha-defensin enhances expression of HSP47 and collagen-1 in human lung fibroblasts. Life Sci 80 (2007) 1839-1845
31. Nakayama S., Mukae H., Sakamoto N., et al. Pirfenidone inhibits the expression of HSP47 in TGF-beta1-stimulated human lung fibroblasts. Life Sci 82 (2008) 210-217